CN110746335B - Polysubstituted pyrrole compound and synthesis method thereof - Google Patents

Polysubstituted pyrrole compound and synthesis method thereof Download PDF

Info

Publication number
CN110746335B
CN110746335B CN201911002944.1A CN201911002944A CN110746335B CN 110746335 B CN110746335 B CN 110746335B CN 201911002944 A CN201911002944 A CN 201911002944A CN 110746335 B CN110746335 B CN 110746335B
Authority
CN
China
Prior art keywords
reaction
general formula
polysubstituted pyrrole
cdcl
nmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201911002944.1A
Other languages
Chinese (zh)
Other versions
CN110746335A (en
Inventor
黄和
李明瑞
黄菲
于杨
孙义明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Normal University
Original Assignee
Nanjing Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Normal University filed Critical Nanjing Normal University
Priority to CN201911002944.1A priority Critical patent/CN110746335B/en
Publication of CN110746335A publication Critical patent/CN110746335A/en
Application granted granted Critical
Publication of CN110746335B publication Critical patent/CN110746335B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a polysubstituted pyrrole compound and a synthesis method thereof. Enamine ketone and alpha-diazo ester are used as initial raw materials, copper salt is used as a catalyst, and under the heating condition, the polysubstituted pyrrole compound is generated through carbene insertion reaction and aryl migration reaction. The method has the advantages of novel and easily-obtained raw materials, simple and convenient operation, simple and mild synthesis reaction conditions and wide substrate universality.

Description

Polysubstituted pyrrole compound and synthesis method thereof
Technical Field
The invention relates to a pyrrole derivative and a synthetic method thereof, in particular to a polysubstituted pyrrole compound and a synthetic method thereof.
Background
Pyrrole is an important class of compounds in pharmaceutical research and is an important backbone structure possessed by many natural products. As a structural unit, pyrrole is one of the basic biochemical entities, and is easily attacked by electrophilicity due to its structural specificity and electron-rich property, and it contains nitrogen atom, so it can interact with many biomolecules through hydrogen bond. These properties make it important in both natural and artificial drugs, and have antiviral, antibacterial, antitumor, antihypercholesterolemic effects (top. heterocyclic. chem., 2006, 2, 53). The currently marketed polysubstituted pyrrole drugs include atorvastatin, nonsteroidal analgesic and anti-inflammatory drugs, tolmetin, chlorfenapyr, and pinworm. The current synthesis methods are as follows: (1) the 1, 4-dicarbonyl compound and the amine compound are subjected to cyclization reaction; (2) adding alkyne, ketone and ammonium salt; (3) reacting the 1, 3-dicarbonyl compound with azide to form a ring; (4) alkyne and isoxazole cyclizations and the like.
The synthesis of polysubstituted pyrazine by taking enaminone and alpha-diazo ester as starting materials has not been reported.
Disclosure of Invention
The purpose of the invention is as follows: the invention aims to provide a polysubstituted pyrrole compound with simple and convenient operation, high yield and various product structures and a synthesis method thereof.
The technical scheme is as follows: the invention provides a polysubstituted pyrrole compound with a general formula 1:
Figure BDA0002240685880000011
wherein R is1Is phenyl or aryl;
R2is phenyl, benzyl, aryl, allyl or alkyl;
R3is hydrogen, a benzene ring or an aryl group;
R4is methyl, ethyl, benzyl or allyl.
Further, the polysubstituted pyrrole compound with the general formula 1 is any one of the following compounds:
Figure BDA0002240685880000021
the synthesis method of the polysubstituted pyrrole compound with the general formula 1 is characterized in that: the method comprises the following steps: the synthetic route is shown as the following reaction formula:
Figure BDA0002240685880000031
1-keto-1-aryl-3- (N, N-dimethyl) amino-2-propene and amine are refluxed in an ethanol solvent to generate enaminone 2 (reaction formula 1). 1, 8-diazabicycloundecen-7-ene (DBU) is used as a catalyst, phenylacetate and p-toluenesulfonyl azide are dissolved in acetonitrile and are placed in a microwave reactor for reaction, and alpha-diazo ester 3 (reaction formula 2) is obtained. Taking enaminone 2 and alpha-diazo ester 3 as initial raw materials, taking copper salt as a catalyst, and generating the polysubstituted pyrrole compound (reaction formula 3) with the general formula 1 through copper carbene intermediate formation, cyclization and aryl migration reaction under the heating condition.
Further, the mol ratio of the enaminone 2 to the alpha-diazo ester 3 is 1:0.1-1: 5. The copper salt is CuCl or CuBr2、Cu(NTf2)2、CuSO4、Cu(NO2)2、Cu(OTf)2、CuOTf、Cu(OAc)2Or [ Cu (MeCN)4]PF6The molar ratio of the enaminone 2 to the copper salt is 1:0.01-1: 1. One or a mixture of two of N, N-Dimethylformamide (DMF), dimethyl sulfoxide (DMSO), Dichloromethane (DCM), 1, 2-Dichloroethane (DCE), 1, 4-dioxane, acetonitrile or toluene is added as a reaction solvent in the synthesis process.
Further, the reaction atmosphere is air, nitrogen or argon; the reaction time is 0.1-48 h; the reaction temperature is 10-120 ℃.
Has the advantages that: the synthesized enamine ketone 2 and alpha-diazo ester 3 have structural diversity, and can synthesize substituted pyrrole derivatives with different types and structures. Synthons 2 and 3 are easy to prepare, the preparation raw materials are cheap and easy to obtain, the cost is low, and the industrial production is easy to realize. The synthesis of the polysubstituted pyrrole compound has good functional group tolerance and diversity, so the polysubstituted pyrrole compound has wide applicability. Different substitution sites of a skeleton of the polysubstituted pyrrole compound are modified to obtain an intermediate of a structure of a medicament and a chemical product, and a 2-site ester group and a 4-site hydrogen atom in the structure are groups capable of being further functionalized. The compound of the invention has significant pharmacological activities of inhibiting cell division and cytotoxin, inhibiting HIV-1 virus integrase, regulating immunity and the like. The synthesis method has the advantages of cheap and easily-obtained raw materials, simple and convenient operation, good yield of target products and capability of further functionalization.
Detailed Description
1-keto-1-aryl-3- (N, N-dimethyl) amino-2-propylene A and amine B are refluxed in an ethanol solvent to generate enaminone 2 (reaction formula 1).
Figure BDA0002240685880000041
The specific process is as follows: dissolving 1-ketone-1-aryl-3- (N, N-dimethyl) amino-2-propylene A (10.0mmol) and organic amine B (20.0mmol) in 30mL ethanol, and stirring in an oil bath at 80 ℃ for reaction for 6 hours. After cooling to room temperature, the volatile components were removed under reduced pressure and then separated by column chromatography on silica gel (eluent petroleum ether (60-90 ℃ C.)/ethyl acetate, v/v 20: 1) to give the desired product 2. The target product is confirmed by the measurement of nuclear magnetic resonance spectrum and high-resolution mass spectrum.
Phenylacetate C is reacted with p-toluenesulfonyl azide D in acetonitrile solvent with 1, 8-diazabicycloundec-7-ene as the base by microwave to produce alpha-diazo ester 3 (equation 2).
Figure BDA0002240685880000042
The specific process is as follows: phenylacetate C (10.0mmol) and p-toluenesulfonyl azide D (11.0mmol) are dissolved in 8ml of acetonitrile, 1, 8-diazabicycloundec-7-ene (15.0mmol) is added dropwise in an ice bath, stirred for 5min and then placed in a microwave reactor for reaction at 40 ℃ for 1h under 40W. Cooled to room temperature, added with 20ml of saturated ammonium chloride, extracted with dichloromethane and water, collected organic phase, dried over anhydrous sodium sulfate, filtered, and subjected to removal of volatile components under reduced pressure, followed by separation by silica gel column chromatography (eluent petroleum ether (60-90 ℃)/ethyl acetate, v/v ═ 100: 1) to obtain the objective product 3. The target product is confirmed by the measurement of nuclear magnetic resonance spectrum and high-resolution mass spectrum.
The following examples are provided to aid in the further understanding of the present invention, but the invention is not limited thereto.
Example 1
Figure BDA0002240685880000043
1-keto-1-phenyl-3-benzylamino-2-propene 2a (0.5mmol) and copper tetraacetonitrile hexafluorophosphate (0.005mmol) were sequentially weighed into a 25mL Schlenk reaction flask, 3mL of acetonitrile was added, the mixture was stirred in an oil bath at 40 ℃ for 2 minutes, and methyl α -diazophenylacetate 3a (0.6mmol) was added and reacted for 20 hours. After the reaction was completed, the mixture was cooled to room temperature, dichloromethane and water were extracted, the organic phase was collected, dried over anhydrous sodium sulfate, filtered, and the volatile components were removed under reduced pressure, followed by separation by silica gel column chromatography (eluent petroleum ether (60-90 ℃)/ethyl acetate, v/v ═ 50: 1) to obtain the objective product 1aa (110mg, yield 60%) as a colorless oil. The target product is confirmed by the measurement of nuclear magnetic resonance spectrum and high-resolution mass spectrum.
Example 2
Figure BDA0002240685880000051
1-keto-1-phenyl-3-benzylamino-2-propene 2a (0.5mmol) and cuprous trifluoromethanesulfonate (0.1mmol) are sequentially weighed and placed in a 25mL Schlenk reaction flask, 2mL of DMF is added, stirring is carried out in an oil bath at 60 ℃ for 2 minutes, ethyl alpha-diazophenylacetate 3b (0.7mmol) is added, and reaction is carried out for 10 hours. After completion of the reaction, the mixture was cooled to room temperature, dichloromethane and water were extracted, the organic phase was collected, dried over anhydrous sodium sulfate, filtered, and the volatile components were removed under reduced pressure, followed by silica gel column chromatography (petroleum ether (60-90 ℃ C.)/ethyl acetate, v/v ═ 50: 1 as the eluent) to give the desired product 1ab (105mg, yield 55%) as a colorless oil. The target product is confirmed by the measurement of nuclear magnetic resonance spectrum and high-resolution mass spectrum.
Example 3
Figure BDA0002240685880000052
1-keto-1-phenyl-3-benzylamino-2-propene 2a (0.5mmol) and copper acetate (0.1mmol) are weighed in sequence into a 25mL Schlenk reaction flask, 2mL of DCE is added, the mixture is stirred in an oil bath at 80 ℃ for 2 minutes, ethyl α -diazoacetate 3c (2.5mmol) is added, after reaction for 48 hours, the mixture is cooled to room temperature, dichloromethane and water are extracted, the organic phase is collected, dried over anhydrous sodium sulfate, filtered, the volatile components are removed under reduced pressure, and then silica gel column chromatography is performed (eluent is petroleum ether (60-90 ℃)/ethyl acetate, v/v is 50: 1) to obtain the target product 1ac (61mg, yield 40%) as colorless oil. The target product is confirmed by the measurement of nuclear magnetic resonance spectrum and high-resolution mass spectrum.
Example 4
Figure BDA0002240685880000053
1-keto-1-phenyl-3-benzylamino-2-propene 2a (4mmol) and copper bromide (0.05mmol) are sequentially weighed into a 25mL Schlenk reaction flask, 3mL of DMSO is added, the mixture is stirred in an oil bath at 80 ℃ for 2 minutes, and then benzyl α -diazoacetate 3d (0.4mmol) is added to react for 24 hours. After the reaction was completed, the mixture was cooled to room temperature, dichloromethane and water were extracted, the organic phase was collected, dried over anhydrous sodium sulfate, filtered, and the volatile components were removed under reduced pressure, followed by silica gel column chromatography (eluent petroleum ether (60-90 ℃)/ethyl acetate, v/v 50: 1) to obtain the target product 1ad (122mg, yield 55%) as a white oil. The target product is confirmed by the measurement of nuclear magnetic resonance spectrum and high-resolution mass spectrum.
Example 5
Figure BDA0002240685880000061
1-keto-1-phenyl-3-benzylamino-2-propene 2a (0.7mmol) and copper sulfate (0.08mmol) are sequentially weighed into a 25mL Schlenk reaction flask, 2mL of toluene is added, stirring is carried out in an oil bath at 120 ℃ for 2 minutes, and alpha-diazophenylacetic acid allyl ester 3e (1.2mmol) is added for reaction for 0.1 hour. After the reaction was completed, the mixture was cooled to room temperature, dichloromethane and water were extracted, the organic phase was collected, dried over anhydrous sodium sulfate, filtered, and the volatile components were removed under reduced pressure, followed by silica gel column chromatography (petroleum ether (60-90 ℃ C.)/ethyl acetate, v/v ═ 50: 1 as the eluent) to give the objective product 1ae (118mg, yield 60%) as a colorless oil. The target product is confirmed by the measurement of nuclear magnetic resonance spectrum and high-resolution mass spectrum.
Example 6
Figure BDA0002240685880000062
1-keto-1-phenyl-3-benzylamino-2-propene 2a (0.5mmol) and copper tetraacetonitrile hexafluorophosphate (0.1mmol) are sequentially weighed into a 25mL Schlenk reaction flask, 2mL of toluene is added, stirring is carried out in an oil bath at 80 ℃ for 2 minutes, 4-bromo-alpha-diazophenylacetic acid methyl ester 3f (1mmol) is added, and the reaction is carried out for 2 hours. After the reaction was completed, the mixture was cooled to room temperature, dichloromethane and water were extracted, the organic phase was collected, dried over anhydrous sodium sulfate, filtered, and the volatile components were removed under reduced pressure, followed by silica gel column chromatography (petroleum ether (60-90 ℃ C.)/ethyl acetate, v/v ═ 50: 1 as eluent) to obtain the desired product 1af (134mg, yield 60%) as a brown oil. The target product is confirmed by the measurement of nuclear magnetic resonance spectrum and high-resolution mass spectrum.
Example 7
Figure BDA0002240685880000071
1-keto-1-phenyl-3-allylamino-2-propene 2b (0.4mmol) and cuprous chloride (0.15mmol) were sequentially weighed into a 25mL Schlenk reaction flask, 2mL of DCE was added, the mixture was stirred in an oil bath at 80 ℃ for 2 minutes, and methyl α -diazophenylacetate 3a (1.2mmol) was added and reacted for 2 hours. After the reaction was completed, the mixture was cooled to room temperature, dichloromethane and water were extracted, the organic phase was collected, dried over anhydrous sodium sulfate, filtered, and the volatile components were removed under reduced pressure, followed by silica gel column chromatography (petroleum ether (60-90 ℃ C.)/ethyl acetate, v/v ═ 50: 1 as eluent) to obtain 1ba (87mg, yield 55%) as the objective product as a colorless oil. The target product is confirmed by the measurement of nuclear magnetic resonance spectrum and high-resolution mass spectrum.
Example 8
Figure BDA0002240685880000072
1-keto-1-phenyl-3- (4-methyl) anilino-2-propene 2c (0.6mmol) and copper trifluoromethanesulfonate (0.05mmol) are weighed in sequence into a 25mL Schlenk reaction flask, 2mL of DCM is added, the mixture is stirred for 2 minutes in an oil bath at 40 ℃, methyl alpha-diazophenylacetate 3a (0.6mmol 1) is added, and the reaction is carried out for 6 hours. After completion of the reaction, the mixture was cooled to room temperature, dichloromethane and water were extracted, the organic phase was collected, dried over anhydrous sodium sulfate, filtered, and the volatile components were removed under reduced pressure, followed by silica gel column chromatography (petroleum ether (60-90 ℃ C.)/ethyl acetate, v/v ═ 50: 1 as an eluent) to give the desired product 1ca as a yellow oil (119mg, yield 65%). The target product is confirmed by the measurement of nuclear magnetic resonance spectrum and high-resolution mass spectrum.
Example 9
Figure BDA0002240685880000073
1-keto-1-phenyl-3- (3-methoxy) anilino-2-propene 2d (0.5mmol) and copper sulfate (0.5mmol) are weighed in sequence into a 25mL Schlenk reaction flask, 4mL of DCM is added, stirring is carried out in an oil bath at 40 ℃ for 2 minutes, methyl alpha-diazophenylacetate 3a (0.5mmol) is added, and reaction is carried out for 12 hours. After completion of the reaction, the mixture was cooled to room temperature, dichloromethane and water were extracted, the organic phase was collected, dried over anhydrous sodium sulfate, filtered, and the volatile components were removed under reduced pressure, followed by silica gel column chromatography (petroleum ether (60-90 ℃ C.)/ethyl acetate, v/v. 50: 1 as eluent) to give the desired product 1da as a yellow oil (119mg, yield 60%). The target product is confirmed by the measurement of nuclear magnetic resonance spectrum and high-resolution mass spectrum.
Example 10
Figure BDA0002240685880000081
1-keto-1-phenyl-3- (4-fluoro) anilino-2-propene 2e (0.5mmol) and copper trifluoromethanesulfonate (0.02mmol) are weighed in sequence into a 25mL Schlenk reaction flask, 2mL of DCE is added, the mixture is stirred in an oil bath at 80 ℃ for 2 minutes, and methyl α -diazophenylacetate 3a (0.7mmol) is added and reacted for 32 hours. After the reaction was completed, the mixture was cooled to room temperature, dichloromethane and water were extracted, the organic phase was collected, dried over anhydrous sodium sulfate, filtered, and the volatile components were removed under reduced pressure, followed by silica gel column chromatography (petroleum ether (60-90 ℃ C.)/ethyl acetate, v/v ═ 50: 1 as the eluent) to obtain the objective product 1ea as a brown oil (115mg, yield 60%). The target product is confirmed by the measurement of nuclear magnetic resonance spectrum and high-resolution mass spectrum.
Example 11
Figure BDA0002240685880000082
1-keto-1- (4-fluoro) phenyl-3-benzylamino-2-propene 2f (1.5mmol) and copper nitrate (0.13mmol) are weighed in sequence into a 25mL Schlenk reaction flask, 5mL of DMF is added, the mixture is stirred in an oil bath at 80 ℃ for 2 minutes, and alpha-diazophenylacetic acid methyl ester 3a (0.6mmol) is added for reaction for 8 hours. After the reaction was completed, the mixture was cooled to room temperature, dichloromethane and water were extracted, the organic phase was collected, dried over anhydrous sodium sulfate, filtered, and the volatile components were removed under reduced pressure, followed by silica gel column chromatography (petroleum ether (60-90 ℃ C.)/ethyl acetate, v/v ═ 50: 1 as eluent) to obtain the objective product 1fa as a brown oil (125mg, yield 65%). The target product is confirmed by the measurement of nuclear magnetic resonance spectrum and high-resolution mass spectrum.
Example 12
Figure BDA0002240685880000091
2g (0.7mmol) of 1-keto-1- (4-chloro) phenyl-3-benzylamino-2-propene and 0.04mmol of cuprous trifluoromethanesulfonate were sequentially weighed and placed in a 25mL Schlenk reaction flask, 5mL of toluene was added, and the mixture was stirred in an oil bath at 80 ℃ for 2 minutes, followed by addition of methyl α -diazophenylacetate 3a (0.8mmol) and reaction for 18 hours. After completion of the reaction, the mixture was cooled to room temperature, dichloromethane and water were extracted, the organic phase was collected, dried over anhydrous sodium sulfate, filtered, and the volatile components were removed under reduced pressure, followed by silica gel column chromatography (petroleum ether (60-90 ℃ C.)/ethyl acetate, v/v ═ 50: 1 as eluent) to give the desired product 1ga (130mg, yield 65%) as a brown oil. The target product is confirmed by the measurement of nuclear magnetic resonance spectrum and high-resolution mass spectrum.
Example 13
Figure BDA0002240685880000092
1-keto-1- (4-bromo) phenyl-3-benzylamino-2-propene was weighed in this order for 2 hours (0.5mmol) and copper nitrate (0.12mmol) in a 25mL Schlenk reaction flask, 5mL of acetonitrile was added, and the mixture was stirred in an oil bath at 80 ℃ for 2 minutes, and then methyl α -diazophenylacetate 3a (0.8mmol) was added and reacted for 16 hours. After the reaction was completed, the mixture was cooled to room temperature, dichloromethane and water were extracted, the organic phase was collected, dried over anhydrous sodium sulfate, filtered, and the volatile components were removed under reduced pressure, followed by silica gel column chromatography (eluent petroleum ether (60-90 ℃)/ethyl acetate, v/v ═ 50: 1) to obtain the objective product 1ha (145mg, yield 65%) as a brown oil. The target product is confirmed by the measurement of nuclear magnetic resonance spectrum and high-resolution mass spectrum.
The characterization data of the target product are as follows:
1-keto-1-phenyl-3-benzylamino-2-propene (2a), yellow solid, m.p.80-83 ℃.1H NMR(400MHz,CDCl3)δ 10.57(s,1H),7.86(dd,J=8.2,1.9Hz,2H),7.16-7.43(m,8H),6.98(dd,J=12.7,7.5Hz,1H),5.74(d,J=7.5Hz,1H),4.41(d,J=6.2Hz,2H).13C{1H}NMR(100MHz,CDCl3)δ 190.1,154.2,139.0,137.6,130.9,128.7,128.3,127.7,127.4,127.0,90.8,52.6.C16H15HRMS theoretical value of NO ([ M + H)]+): 238.1154, respectively; measurement value: 238.1147.
methyl α -diazophenylacetate (3a), an orange oily liquid.1H NMR(400MHz,CDCl3)δ7.49(dd,J=8.5,1.1Hz,2H),7.39(t,J=7.9Hz,2H),7.19(t,J=7.4Hz,1H),3.87(s,3H).13C{1H}NMR(100MHz,CDCl3) HRMS theoretical values ([ M + H ] of delta 165.55, 128.94, 125.82, 125.48, 123.92, 51.97.C9H9O2]+): 177.0586 measurement: 177.0588.
1-benzyl-2-carbomethoxy-3-phenyl-5-phenylpyrrole derivative (1aa), colorless oily liquid.1H NMR(400MHz,CDCl3)δ7.38(dd,J=8.3,1.3Hz,2H),7.32-7.26(m,7H),7.22(d,J=7.3Hz,1H),7.16(d,J=8.1Hz,2H),7.11(t,J=7.3Hz,1H),6.84(d,J=7.1Hz,2H),6.27(s,1H),5.53(s,2H),3.44(s,3H).13C{1H}NMR(100MHz,CDCl3)δ162.10,140.80,139.29,136.48,134.13,131.91,129.44,129.29,128.50,128.45,128.30,127.59,126.82,126.65,125.65,119.30,112.16,50.75,49.65.C26H23NO2HRMS theoretical value of ([ M + H ]]+): 368.1572, respectively; measurement value: 368.1566.
1-benzyl-2-carbethoxy-3-phenyl-5-phenylpyrrole derivative (1ab), colorless oily liquid.1H NMR(400MHz,CDCl3)δ7.50(d,J=7.0Hz,2H),7.41(d,J=1.9Hz,1H),7.39(d,J=1.4Hz,4H),7.38-7.36(m,2H),7.33(d,J=7.3Hz,1H),7.28(t,J=7.3Hz,2H),7.22(t,J=7.3Hz,1H),6.96(d,J=7.2Hz,2H),6.38(s,1H),5.65(s,2H),4.05(q,J=7.1Hz,2H),0.98(t,J=7.1Hz,3H).13C{1H}NMR(100MHz,CDCl3)δ161.83,140.70,139.53,136.77,134.19,132.14,129.62,129.60,128.64,128.60,128.40,127.63,126.93,126.75,125.84,119.85,112.20,59.99,49.76,13.76.C27H25NO2HRMS theoretical value of ([ M + H ]]+): 382.1729, respectively; measurement value: 382.1735.
1-benzyl-2-carbethoxy-3-hydro-5-phenylpyrrole derivative (1ac) as a colorless oily liquid.1H NMR(400MHz,CDCl3)δ7.36(d,J=1.8Hz,1H),7.33(d,J=2.9Hz,1H),7.32(s,2H),7.30(s,2H),7.26(s,2H),7.24(s,1H),6.99(d,J=6.7Hz,2H),6.66(d,J=1.8Hz,1H),5.10(s,2H),4.27(q,J=7.1Hz,2H),1.32(t,J=7.1Hz,3H).13C{1H}NMR(100MHz,CDCl3)δ164.99,137.55,135.94,132.23,129.26,128.94,128.62,127.89,127.86,127.71,126.80,116.31,110.08,59.87,51.29,14.61.C20H19NO2HRMS theoretical value of ([ M + H ]]+): 306.1416, respectively; measurement value: 306.1419.
1-benzyl-2-carbobenzoxy-3-phenyl-5-phenylpyrrole derivative (1ad), colorless oily liquid.1H NMR(400MHz,CDCl3)67.40(dd,J=7.6,1.9Hz,2H),7.36-7.31(m,5H),7.29-7.24(m,3H),7.24-7.18(m,3H),7.15(m,3H),6.88(t,J=6.7Hz,4H),6.32(s,1H),5.60(s,2H),5.00(s,2H).13C{1H}NMR(100MHz,CDCl3)δ161.56,141.00,139.42,136.75,135.80,134.67,132.05,129.63,129.58,128.63,128.60,128.44,128.23,127.99,127.76,127.74,126.95,126.74,125.84,119.46,112.44,65.70,49.77.C31H25NO2HRMS theoretical value of ([ M + H ]]+): 444.185, respectively; measurement value: 444.1881.
1-benzyl-2-allylester-3-phenyl-5-phenylpyrrole derivative (1ae) as colorless oily liquid.1H NMR(400MHz,CDCl3)δ7.44(d,J=7.1Hz,2H),7.37-7.29(m,7H),7.28-7.19(m,3H),7.15(t,J=7.2Hz,1H),6.90(d,J=7.3Hz,2H),6.32(s,1H),5.59(s,2H),5.58-5.51(m,1H),4.95(dd,J=10.5,1.2Hz,1H),4.86(d,J=17.2,1.2Hz,1H),4.44(d,J=5.5Hz,2H).13C{1H}NMR(100MHz,CDCl3)δ161.44,140.96,139.41,136.68,134.52,132.05,131.94,129.59,129.57,128.62,128.57,128.42,127.70,126.94,126.78,125.82,119.47,117.62,112.33,64.71,49.76.C27H23NO2HRMS theoretical value of ([ M + H ]]+): 394.1729, respectively; measurement value: 294.1727.
1-benzyl-2-carbomethoxy-3- (4-bromo) phenyl-5-phenylpyrrole derivative (1af), yellow oily liquid.1H NMR(400MHz,CDCl3)δ7.48(d,J=8.4Hz,2H),7.35(s,5H),7.32(d,J=8.4Hz,2H),7.24(t,J=7.3Hz,2H),7.18(t,J=7.2Hz,1H),6.90(d,J=7.3Hz,2H),6.30(s,1H),5.59(s,2H),3.53(s,3H).13C{1H}NMR(100MHz,CDCl3)δ161.94,141.11,139.25,135.61,132.98,131.84,131.13,130.81,129.56,128.66,128.60,12854,127.02,125.77,120.88,119.39,112.10,50.93,49.85.C25H20BrNO2HRMS theoretical value of ([ M + H ]]+): 446.0677, respectively; measurement value: 446.0679.
1-allyl-2-carbomethoxy-3-phenyl-5-phenylpyrrole derivative (1ba), colorless oily liquid.1H NMR(400MHz,CDCl3)δ7.50-7.44(m,5H),7.43-7.29(m,5H),6.30(s,1H),6.00(dd,J=17.2,10.4Hz,1H),5.14(dd,J=10.4,1.2Hz,1H),5.03-4.94(m,2H),4.88(dd,J=17.2,1.2Hz,1H),3.66(s,3H).13C{1H}NMR(100MHz,CDCl3)δ162.37,140.42,136.76,135.76,133.87,132.14,129.58,129.42,128.53,128.42,127.70,126.71,119.08,115.55,112.05,50.88,48.58.C21H19NO2HRMS theoretical value of ([ M + H ]]+): 318.1416, respectively; measurement value: 318.1415.
1- (4-methyl)) Phenyl-2-carbomethoxy-3-phenyl-5-phenylpyrrole derivative (1ca), colorless oily liquid.1H NMR(400MHz,CDCl3)δ7.53(d,J=7.1Hz,2H),7.41(t,J=7.4Hz,2H),7.33(t,J=7.3Hz,1H),7.22-7.18(m,3H),7.17-7.10(m,6H),6.48(s,1H),3.51(s,3H),2.38(s,3H).13C{1H}NMR(100MHz,CDCl3)δ161.94,139.79,137.86,136.84,136.25,133.39,132.02,129.41,129.23,129.03,128.35,128.12,127.86,127.46,126.93,121.45,112.19,51.00,21.37.C25H21NO2HRMS theoretical value of ([ M + H ]]+): 368.1572, respectively; measurement value: 368.1577.
1- (3-methoxy) benzyl-2-carbomethoxy-3-phenyl-5-phenylpyrrole derivative (1da) as a colorless oily liquid.1H NMR(400MHz,CDCl3)δ7.45(d,J=7.1Hz,2H),7.39-7.35(m,7H),7.30(t,J=7.3Hz,1H),7.17(t,J=7.9Hz,1H),6.73(d,J=10.4Hz,1H),6.52(d,J=7.6Hz,1H),6.45(s,1H),6.34(s,1H),5.58(s,2H),3.72(s,3H),3.54(s,3H).13C{1H}NMR(100MHz,CDCl3)δ161.12,158.73,140.00,139.81,135.53,133.18,130.93,128.50,128.46,128.33,127.53,127.31,126.59,125.66,118.34,117.04,111.24,111.21,110.35,54.06,49.78,48.55.C26H23NO3HRMS theoretical value of ([ M + H ]]+): 398.4740, respectively; measurement value: 398.4718.
1- (4-fluoro) benzyl-2-carbomethoxy-3-phenyl-5-phenylpyrrole derivative (1ea) as a yellow oily liquid.1H NMR(400MHz,CDCl3)δ7.49(d,J=7.0Hz,2H),7.44-7.37(m,7H),7.33(t,J=7.3Hz,1H),6.97(t,J=8.7Hz,2H),6.92(t,J=7.1Hz,2H),6.38(s,1H),5.60(s,2H),3.58(s,3H).13C{1H}NMR(100MHz,CDCl3)δ,162.27,161.86(d,J=243.4Hz),160.64,140.90,136.51,135.06(d,J=3.1Hz),134.42,131.95,129.56,129.41,128.68,128.52,127.74,127.54(d,J=8Hz),126.85,119.31,115.43(d,J=21.5Hz).,112.45,50.90,49.08.C25H20FNO2HRMS theoretical value of ([ M + H ]]+): 386.1478, respectively; measurement value: 386.1477.
1-benzyl-2-carbomethoxy-3-phenyl-5- (4-fluoro) phenylpyrrole derivative (1fa), yellow oily liquid.1H NMR(400MHz,CDCl3)δ7.35(d,J=7.0Hz,2H),7.26(t,J=7.4Hz,2H),7.20(m,3H),7.15(t,J=7.3Hz,2H),7.09(d,J=7.2Hz,1H),6.93(t,J=8.7Hz,2H),6.80(d,J=7.2Hz,2H),6.21(s,1H),5.47(s,2H),3.42(s,3H).13C{1H}NMR(100MHz,CDCl3)δ162.85(d,J=248.6Hz),162.20,139.73,139.24,136.49,134.14,131.38(d,J=8.2Hz),129.40,128.64,128.10(d,J=3.4Hz),127.74,127.04,126.84,125.71,119.52,115.66(d,J=21.6Hz),112.36,50.89,49.70.C25H20FNO2HRMS theoretical value of ([ M + H ]]+): 386.1478, respectively; measurement value: 386.1476.
1-benzyl-2-carbomethoxy-3-phenyl-5- (4-chloro) phenylpyrrole derivative (1ga), brown oily liquid.1H NMR(400MHz,CDCl3)δ7.34(d,J=7.1Hz,2H),7.26(t,J=7.4Hz,2H),7.21(d,J=6.5Hz,1H),7.20-7.17(m,3H),7.15(t,J=7.4Hz,3H),7.08(t,J=7.3Hz,1H),6.80(d,J=7.2Hz,2H),6.23(s,1H),5.47(s,2H),3.42(s,3H).13C{1H}NMR(100MHz,CDCl3)δ162.13,139.50,139.15,136.39,134.55,134.18,130.76,130.44,129.37,128.86,128.65,127.74,127.07,126.86,125.66,119.82,112.46,50.91,49.75.C25H20ClNO2HRMS theoretical value of ([ M + H ]]+): 402.4483, respectively; measurement value: 402.4487.
1-benzyl-2-carbomethoxy-3-phenyl-5- (4-bromo) phenylpyrrole derivative (1ha), brown oily liquid.1H NMR(400MHz,CDCl3)δ7.46-7.39(m,4H),7.33(t,J=7.4Hz,2H),7.26(d,J=7.3Hz,1H),7.22(t,J=7.4Hz,2H),7.18-7.12(m,3H),6.87(d,J=7.2Hz,2H),6.30(s,1H),5.54(s,2H),3.49(s,3H).13C{1H}NMR(100MHz,CDCl3)δ162.10,139.48,139.12,136.35,134.19,131.80,131.00,130.88,129.36,128.65,127.73,127.07,126.85,125.64,122.76,119.86,112.43,50.90,49.74.C25H20BrNO2HRMS theoretical value of ([ M + H ]]+): 445.0677, respectively; measurement value: 445.0679.

Claims (4)

1. a synthetic method of polysubstituted pyrrole compounds with a general formula 1 is characterized in that: the method comprises the following steps: the synthetic route is shown as the following reaction formula:
Figure DEST_PATH_IMAGE001
taking enaminone 2 and alpha-diazo ester 3 as initial raw materials, taking copper salt as a catalyst, and generating a polysubstituted pyrrole compound with a general formula 1 through copper carbene intermediate formation, cyclization and ester group transfer reaction under the heating condition,
wherein R is1Is aryl;
R2is aryl, benzyl or allyl;
R3is hydrogen or aryl;
R4is methyl, ethyl, benzyl or allyl;
the mol ratio of the enaminone 2 to the alpha-diazo ester 3 is 1:0.1-1: 5;
the copper salt is CuCl or CuBr2、Cu(NTf2)2、CuSO4、Cu(NO2)2、Cu(OTf)2、CuOTf、Cu(OAc)2Or [ Cu (MeCN) 4]PF6The molar ratio of the enaminone 2 to the copper salt is 1:0.01-1: 1.
2. The method for synthesizing polysubstituted pyrrole compounds having general formula 1 according to claim 1, wherein: the polysubstituted pyrrole compound with the general formula 1 is any one of the following compounds:
Figure 632301DEST_PATH_IMAGE003
Figure DEST_PATH_IMAGE005
3. the method for synthesizing polysubstituted pyrrole compounds having general formula 1 according to claim 1, wherein: one or a mixture of two of N, N-Dimethylformamide (DMF), dimethyl sulfoxide (DMSO), Dichloromethane (DCM), 1, 2-Dichloroethane (DCE), 1, 4-dioxane, acetonitrile or toluene is added as a reaction solvent in the synthesis process.
4. The method for synthesizing polysubstituted pyrrole compounds having general formula 1 according to claim 1, wherein: the reaction atmosphere is air, nitrogen or argon; the reaction time is 0.1-48 h; the reaction temperature is 10-120 ℃.
CN201911002944.1A 2019-10-21 2019-10-21 Polysubstituted pyrrole compound and synthesis method thereof Active CN110746335B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911002944.1A CN110746335B (en) 2019-10-21 2019-10-21 Polysubstituted pyrrole compound and synthesis method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911002944.1A CN110746335B (en) 2019-10-21 2019-10-21 Polysubstituted pyrrole compound and synthesis method thereof

Publications (2)

Publication Number Publication Date
CN110746335A CN110746335A (en) 2020-02-04
CN110746335B true CN110746335B (en) 2021-03-19

Family

ID=69279264

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911002944.1A Active CN110746335B (en) 2019-10-21 2019-10-21 Polysubstituted pyrrole compound and synthesis method thereof

Country Status (1)

Country Link
CN (1) CN110746335B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113200902B (en) * 2019-11-27 2022-11-11 云南大学 Polysubstituted pyrrole derivative and preparation method thereof
CN112094218B (en) * 2020-09-04 2024-01-26 湖北科技学院 Synthesis method of pyrrole derivative
CN112592310B (en) * 2020-12-21 2022-04-29 南京工业大学 2-hydroxypyridine compound and synthetic method thereof
CN115477627B (en) * 2022-05-23 2023-12-22 南京工业大学 Polysubstituted 2-furanone compound and synthesis method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101798279A (en) * 2010-03-23 2010-08-11 东北师范大学 Method for preparing iron-catalyzed pyrrole and pyrrole cyclic compounds
CN103145600A (en) * 2013-03-06 2013-06-12 东北师范大学 Synthesis method of silver-catalyzed polysubstitued pyrrole compounds
CN106565583A (en) * 2016-11-15 2017-04-19 淮阴师范学院 Preparation method of polysubstitued pyrrole derivative

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101798279A (en) * 2010-03-23 2010-08-11 东北师范大学 Method for preparing iron-catalyzed pyrrole and pyrrole cyclic compounds
CN103145600A (en) * 2013-03-06 2013-06-12 东北师范大学 Synthesis method of silver-catalyzed polysubstitued pyrrole compounds
CN106565583A (en) * 2016-11-15 2017-04-19 淮阴师范学院 Preparation method of polysubstitued pyrrole derivative

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
Catalyzed Reaction of Diazodiphenylethanone and Related Diazo Ketones with Enaminones as a Source of Pyrroles;Marcos N. Eberlin et al.;《J. Org. Chem.》;19880401;第53卷;第2084-2086页 *
DBU-promoted tandem Michael-addition/cyclization for the synthesis of polysubstituted pyrroles;Tianyu Yang et al.;《Tetrahedron》;20190228;第75卷;第2291-2297页 *
Facile Regiocontrolled Three-Step Synthesis of Poly-Substituted Furans, Pyrroles,and Thiophenes: Consecutive Michael Addition of Methyl Cyanoacetate to α,β-Enone,CuI-Mediated Aerobic Oxidation, and Acid-Catalyzed Paal-Knorr Synthesis;Se Hee Kim et al.;《Bull. Korean Chem. Soc》;20120220;第33卷(第2期);第620-624页 *
Se Hee Kim et al..Facile Regiocontrolled Three-Step Synthesis of Poly-Substituted Furans, Pyrroles,and Thiophenes: Consecutive Michael Addition of Methyl Cyanoacetate to α,β-Enone,CuI-Mediated Aerobic Oxidation, and Acid-Catalyzed Paal-Knorr Synthesis.《Bull. Korean Chem. Soc》.2012,第33卷(第2期),第620-624页. *
Synthesis of 2,2"-Dipyrryl Ketones from Pyrrole-2-carboxylic Acids with Trifluoroacetic Anhydride;Se Hee Kim et al.;《Bull. Korean Chem. Soc》;20140131;第34卷(第9期);第2604-2608页 *
Tianyu Yang et al..DBU-promoted tandem Michael-addition/cyclization for the synthesis of polysubstituted pyrroles.《Tetrahedron》.2019,第75卷第2291-2297页. *
基于α-羰基重氮化合物参与的N—H 插入反应的研究进展;封佳俊等;《有机化学》;20190709;第39卷;第3013-3025页 *

Also Published As

Publication number Publication date
CN110746335A (en) 2020-02-04

Similar Documents

Publication Publication Date Title
CN110746335B (en) Polysubstituted pyrrole compound and synthesis method thereof
Han et al. Efficient synthesis of pentasubstituted pyrroles via one-pot reactions of arylamines, acetylenedicarboxylates, and 3-phenacylideneoxindoles
CN107805232B (en) Synthetic method of derivative containing methylthio furan
CN109867643B (en) Polysubstituted furan derivative and synthesis thereof
CN107793385B (en) Synthetic method of furan derivative
CN110204533B (en) Preparation method of 4- (isochromen-1-yl) isoquinoline derivative
CN109400611B (en) Synthesis method of 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound
CN112898259B (en) Method for preparing 3-substituted chromanone through nonmetal catalytic hydrogenation
CN108218804B (en) 4-alkylthio-3-isoxazolone derivative and synthesis method thereof
CN114380790B (en) Polysubstituted thiopyran derivative and synthetic method thereof
CN105820174A (en) Polysubstituted thienoindole derivative and preparation method thereof
CN113387886B (en) 2-aminodibenzo [ c, e ] azepine compound and synthetic method thereof
CN110256451B (en) Synthetic method of benzofuro [2,3-b ] quinoline derivative
CN109503387B (en) Method for catalyzing asymmetric synthesis of binaphthyl diamine
CN108467382B (en) Preparation method of 4H-chromene derivative
CN109251192B (en) Preparation method of 3-position or 4-position trifluoromethyl substituted isocoumarin
CN115477627B (en) Polysubstituted 2-furanone compound and synthesis method thereof
CN112939903A (en) Method for preparing furan compound from aryl ketone bromide
CN108383803B (en) Synthetic method of 2, 4-disubstituted oxazole
CN108503578B (en) Synthetic method of indeno- [1,2-b ] indole-10 (5H) -ketone compound
CN111018827A (en) Polysubstituted thiophene derivative and synthetic method thereof
CN115304557B (en) Enamine derivative and preparation method thereof
CN115197135B (en) Method for preparing polysubstituted quinoline compound by zinc catalysis
CN114181182B (en) Synthesis method of polysubstituted 4H-pyran compound
CN111269210B (en) Cyanoalkyl substituted thiophene derivative and synthesis thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant